Parkinson’s Disease Treatment Market Reflect Impressive Growth Rate in Pharmaceutical Industry

Parkinson's Disease Treatment Market

Pune, India, 2020-May-11 — /EPR Network/ — The Parkinson’s disease treatment market was valued at USD 3.99 billion in 2016 and expected to grow at a CAGR of 6.1% from 2017 to 2022 to reach USD 5.69 billion in 2022. The carbidopa/levodopa drug class is projected to register highest CAGR during forecast period. The major driving factors for this market include ageing population and government funding for research, growing healthcare awareness. The base year considered for the study is 2016, and the forecast has been provided for the period between 2018 and 2023.

  • Government funding for research
  • Strong pipeline
  • In 2016, Sun Pharmaceutical Industries Ltd. (India) entered distribution agreement with Mitsubishi Tanabe Pharma Corporation (Japan) to distribute 14 prescription brands that include Parkinson’s disease drug Parlodel in Japan
  • What are the restraining factors for this market?

Matched content

Editor’s pick

Express Press Release Distribution